Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists

Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists

Cardiovascular disease remains one of the most prominent global health problems and has been demonstrated to disproportionally affect certain communities. Despite an increasing collective effort to improve health inequalities, a multitude of disparities continue to affect cardiovascular outcomes. Am...

Descripció completa

Dades bibliogràfiques
Autors principals: Apurva Khedagi, Cara Hoke, Michelle Kelsey, Andrea Coviello, W. Schuyler Jones, Larry R. Jackson, II, Manesh R Patel, Rob W. McGarrah, Neha J Pagidipati, Nishant P. Shah
Format: Article
Idioma:English
Publicat: Elsevier 2023-03-01
Col·lecció:American Journal of Preventive Cardiology
Matèries:
Disparities
Prevention
Health equity
SGLT2i
GLP1-RA
Accés en línia:http://www.sciencedirect.com/science/article/pii/S2666667723000193

Internet

http://www.sciencedirect.com/science/article/pii/S2666667723000193

Ítems similars